This compound is primarily utilized in the development of antibacterial agents, particularly in the synthesis of quinolone-based antibiotics. Its structure is key in targeting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication. The presence of the cyclopropyl and piperazine groups enhances its ability to penetrate bacterial cells and improve binding affinity. Researchers focus on modifying its structure to enhance efficacy against resistant bacterial strains, making it valuable in addressing antibiotic resistance. Additionally, it serves as an intermediate in the production of more complex pharmaceutical compounds aimed at treating a wide range of bacterial infections.